Sugi Predict

Sugi Predict / Compounds / Kinetin

Kinetin

Kinetin

SCHEMBL2138115

Nc1ncnc2[nH]cnc12.c1coc(CNc2[nH]cnc3ncnc2-3)c1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 9/20 0.45
▸ TSHR P16473 4/20 0.45
▸ ADORA3 P0DMS8 2/20 0.45
▸ HIF1A Q16665 2/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ ALOX15 P16050 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ KDR P35968 1/20 0.45
▸ POLB P06746 3/20 0.40
▸ ADORA2A P29274 1/20 0.38
▸ ADORA2B P29275 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ KDM4A O75164 1/20 0.38
▸ KDM4B O94953 1/20 0.38
▸ KDM5C P41229 1/20 0.38
▸ KDM5B Q9UGL1 1/20 0.38
▸ CCNB2 O95067 2/20 0.37
▸ CDK1 P06493 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Kinetin SCHEMBL10938935 0.94 SMN1; SMN2 (0.41) SMN1; SMN2TSHRADORA3HIF1AMEN1
Kinetin SCHEMBL17847289 0.89 SMN1; SMN2 (0.53) SMN1; SMN2TSHRADORA3HIF1AMEN1
Kinetin SCHEMBL23818 0.89 SMN1; SMN2 (0.54) SMN1; SMN2TSHRADORA3HIF1AMEN1
Kinetin SCHEMBL458140 0.89 SMN1; SMN2 (0.54) SMN1; SMN2TSHRADORA3HIF1AMEN1
Kinetin SCHEMBL584400 0.88 SMN1; SMN2 (0.53) SMN1; SMN2TSHRADORA3HIF1AMEN1
Kinetin SCHEMBL9125232 0.88 SMN1; SMN2 (0.53) SMN1; SMN2TSHRADORA3HIF1AMEN1
Kinetin SCHEMBL3486607 0.84 SMN1; SMN2 (0.48) SMN1; SMN2TSHRADORA3HIF1AMEN1
6-Benzylaminopurine SCHEMBL6864326 0.84 SMN1; SMN2 (0.47) SMN1; SMN2TSHRADORA3HIF1AMEN1
Kinetin SCHEMBL11692724 0.82 SMN1; SMN2 (0.48) SMN1; SMN2TSHRADORA3HIF1AMEN1
6-Benzylaminopurine SCHEMBL1708008 0.82 SMN1; SMN2 (0.48) SMN1; SMN2TSHRADORA3HIF1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008128847-A1 IN VITRO MULTIPLICATION OF HOODIA PLANTS UNILEVER N.V. (NL) 2008-10-30 — — WO claimed
US-20080261309-A1 IN VITRO MULTIPLICATION OF HOODIA PLANTS CONOPCO, INC., D/B/A/ UNILEVER (US) 2008-10-23 — — US claimed
US-12011496-B2 Topical macqui berry formulation Tracie Martyn International, Inc. (US) 2024-06-18 — — US disclosed
CN-114315835-B 6-benzyladenine hapten, artificial antigen, antibody and preparation method and application thereof 华南农业大学 2023-03-03 — — CN disclosed
CN-113349054-B Culture medium for inhibiting endophyte and material browning in tissue culture of date palm and application 中国热带农业科学院椰子研究所 2022-07-15 — — CN disclosed
CN-113439751-B Date palm field sampling treatment agent and preparation method and use method thereof 中国热带农业科学院椰子研究所 2022-07-12 — — CN disclosed
CN-114315835-A 6-benzyladenine hapten, artificial antigen, antibody and preparation method and application thereof 华南农业大学 2022-04-12 — — CN disclosed
CN-113439751-A Date palm field sampling treatment agent and preparation method and use method thereof 中国热带农业科学院椰子研究所 2021-09-28 — — CN disclosed
CN-113349054-A Culture medium for inhibiting endophyte and material browning in date palm tissue culture and application 中国热带农业科学院椰子研究所 2021-09-07 — — CN disclosed
US-10993897-B2 Topical macqui berry formula Tracie Martyn International, Inc. (US) 2021-05-04 — — US disclosed
CN-110637826-A Plant growth regulator and preparation method and application thereof 江西鑫邦生化有限公司 2020-01-03 — — CN disclosed
US-20080261310-A1 IN VITRO ROOTING OF HOODIA PLANTS CONOPCO, INC., D/B/A/ UNILEVER (US) 2008-10-23 — — US disclosed
US-20080261309-A1 IN VITRO MULTIPLICATION OF HOODIA PLANTS CONOPCO, INC., D/B/A/ UNILEVER (US) 2008-10-23 — — US disclosed
US-20080039322-A1 Stable and Water-Soluble Plant Growth Regulator Liquid Compositions and Methods for Use of Same WANG YUEH 2008-02-14 — — US disclosed
US-20070065396-A1 Topical macqui berry formulation TRACIE MARTYN INTERNATIONAL, LLC 2007-03-22 — — US disclosed
EP-1758449-A1 STABLE AND WATER-SOLUBLE PLANT GROWTH REGULATOR LIQUID COMPOSITIONS AND METHODS FOR USE OF SAME Valent Biosciences Corporation (US) 2007-03-07 — — EP disclosed
US-20060216251-A1 Topical formulations and methods of use TRACIE MARTYN INTERNATIONAL, LLC (US) 2006-09-28 — — US disclosed
WO-2006026713-A2 TOPICAL BENFOTIAMINE AND PYRIDOXAMINE COMPOSITIONS TRACIE MARTYN INTERNATIONAL, LLC (US) 2006-03-09 — — WO disclosed
US-20060045896-A1 Topical compositions comprising benfotiamine and pyridoxamine TRACIE MARTYN INTERNATIONAL, LLC 2006-03-02 — — US disclosed
WO-2005115142-A1 STABLE AND WATER-SOLUBLE PLANT GROWTH REGULATOR LIQUID COMPOSITIONS AND METHODS FOR USE OF SAME VALENT BIOSCIENCES CORPORATION (US) 2005-12-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060216251-A1 Topical formulations and methods of use CPT1B, SLC25A20, CPT1A SMN1; SMN2 1808/4885TSHR 4564/4885ADORA3 1165/4885
US-20060045896-A1 Topical compositions comprising benfotiamine and pyridoxamine AGER, LPO, LOX SMN1; SMN2 4425/4885TSHR 2487/4885ADORA3 727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.